American takes over Jerusalem Gate Hotel [pg. 15]

April 17, 2006 04:33


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user uxperience almost completely free of ads
  • Access to our Premium Section and our monthly magazine to learn Hebrew, Ivrit
  • Content from the award-winning Jerusalem Repor
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The Jerusalem Gate Hotel, at the entrance to the capital, has this month been officially taken over by American entrepreneur and investor Morris Wilner from the Dag Hakesef Company for an undisclosed sum. Wilner, who also has purchased the adjacent "Center 1" shopping mall, has numerous investments in Israel, in general, and Jerusalem, in particular. Even though the hotel underwent major renovations not long ago, Wilner intends to upgrade it by expanding on the improvements in an effort to attract tourists from around the globe. A resident of Philadelphia, Wilner was the developer or partner in numerous residential and commercial projects in Philadelphia, as well as New Jersey, New York and Florida. In addition to his many business interests, he is a member of the executive committee of AIPAC, and chairman of the Friends of Elwyn, which helps people with special needs.

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection